Bioventus (BVS) Non-Current Debt (2020 - 2026)
Bioventus' (BVS) quarterly Non-Current Debt came in at $253.3 million in Q1 2026, down 17.91% YoY from $308.6 million in Q1 2025, and down 9.19% on a QoQ basis from $279.0 million in Q4 2025.
Bioventus (BVS) Non-Current Debt (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Non-Current Debt data on file, last reported at $253.3 million in Q1 2026.
- Quarterly Non-Current Debt fell 17.91% year-over-year to $253.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.3 million (down 17.91% YoY) and the FY2025 annual result came in at $279.0 million, down 9.52% from the prior year.
- Non-Current Debt eased to $253.3 million in Q1 2026, from $279.0 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $404.3 million in Q2 2023 to a low of $253.3 million in Q1 2026.
- A 5-year average of $341.3 million and a median of $348.0 million in 2022 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt jumped 142.0% — and 2026, when it retreated 17.91%.
- Tracing BVS's Non-Current Debt over 5 years: stood at $385.0 million in 2022, then dropped by 4.68% to $367.0 million in 2023, then decreased by 16.0% to $308.3 million in 2024, then decreased by 9.52% to $279.0 million in 2025, then fell by 9.19% to $253.3 million in 2026.
- The last three Non-Current Debt figures came in at $253.3 million (Q1 2026), $279.0 million (Q4 2025), and $311.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 229.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 229.70 Mn |
| Mar 28, 2026 | 253.33 Mn |
| Dec 31, 2025 | 278.95 Mn |
| Sep 27, 2025 | 311.33 Mn |
| Jun 28, 2025 | 297.88 Mn |
| Mar 29, 2025 | 308.59 Mn |
| Dec 31, 2024 | 308.29 Mn |
| Sep 28, 2024 | 345.02 Mn |
| Jun 29, 2024 | 344.72 Mn |
| Mar 30, 2024 | 355.43 Mn |
| Dec 31, 2023 | 367.00 Mn |
| Sep 30, 2023 | 375.03 Mn |
| Jul 1, 2023 | 374.57 Mn |
| Apr 1, 2023 | 404.27 Mn |
| Dec 31, 2022 | 385.01 Mn |
| Oct 1, 2022 | 393.10 Mn |
| Jul 2, 2022 | 351.43 Mn |
| Apr 2, 2022 | 348.04 Mn |
| Dec 31, 2021 | 339.64 Mn |
| Oct 2, 2021 | 162.44 Mn |